Clinical Trial Update: Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a combination of rimonabant and metformin for glycemic control in type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rimonabant (rimonabant)
• metformin (metformin)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED